Member Info for Num4

Some interesting trades today, a 11111 trade followed by 5million buys, being reported late obviously, check advfn trades 10:44. Single buyer imo, TR1 soon surely.

I think the filter list might be increasing soon.

I don't think any of us anticipated a launch platform of just under a penny, the interest before the lupus paper was substantial and I don't even think that was the reason, a nice brucey bonus as such. Real COVID news by end of next week imo.

Iceman - there is not many on here who haven't done their homework - we are all distinction grades on Sareum potential.

Someone is clearly buying the dips and has been for the last 4 sessions, at least. This is not the normal for Sareum. Hold for the updates Basil has said all should be within a few months maximum. Their strategy is license pre-clinical or early clinical, and remember they have 2 compounds. We will find out very soon imo.

See how the panic sets in today when people see the drop, all just normal here.

https://www.google.com/amp/s/amp.scroll.in/article/955271/targeting-this-gene-could-help-scientists-fight-at-least-20-autoimmune-diseases

Nice find and I think Sareum will tweet this, except not the daily mail article, if it is published on a industry site then they will tweet imo. I like Tim to follow up with some comments and not just a direct retweet - did you hear that Tim!.

I think Mr. Higgs originally posted the research which lead to my first purchase, probably around 2008.

That could be for our SKIL platform ONLY.

Good to hear that, afterall we are all here to make money and the combined research and thoughts have helped us all become very comfortable with this investment at these levels.

Nice addition to the board, welcome! I look forward to more of your posts.

Always hard to identify whether buys or sells and unless you actually made them trades then the most reliable way is the direction of the share price, either way buys or sells, we are still moving in the right direction.

Just to add, my posts are all IMO, I know no more than anyone else here. I would say that any heavy buying into the close would indicate an RNS the next day, but that's again IMO and just common sense really.

We may get a research update on the Tyk2s in August, similar to last year, it may be sooner as we will be just waiting for final studies to complete now, no new preclinical studies should be ongoing. Confirmation of MTD reached in next update and then await the confirmation of clinical trial application and confirmed targets.

As long as the buys keep coming on them dips, like just now, we are all good to maintain levels here and advance

Tim has mentioned a few times about differentiation being a big factor with comparable compounds, when we compare against BMS, is the advantage/differentiator the fact that we target the active site and they don't, they use allosteric inhibition of the target site, Tyk2?
Active site inhibition is mentioned as being a formidable challenge..
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00444

White hot! I like!

Is the maintained volume, which started before the lupus paper RNS, which was forced through Citizen being on the ball!
Volumes continues to be morning heavy and buying on any dip. If this continues all week, which would be a 1st for Sareum then I would expect a TR1 RNS in due course.
But I don't believe we know the true reason for this increased interest, the fact that Sareum didn't put the breaks in it means it has substance.

Agree!

I think you could easily create a website and post updated 2020 codes for AIM, in no time at all you would find them the new folklores. Hahaa